fashion -WSS

fashion

author：knowledge 2025-09-30 12:21:45 - browse：67837

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — The booming obesity market is attracting another player, as pharma giant Roche said Monday it was acquiring Carmot Therapeutics and the company’s line of weight loss drug candidates for $2.7 billion upfront.

The deal for Carmot, which is based in Berkeley, Calif., includes additional milestone payments of up to $400 million. Carmot is privately held, though it had filed paperwork last month for an initial public offering.

As part of the deal, Roche is gaining three experimental obesity medicines from Carmot, which are in Phase 1 or Phase 2 testing, as well as preclinical programs. While two are injectable treatments, one is being developed as an oral drug. They all target GLP-1 hormone receptors, while two are also designed to work via receptors for another hormone called GIP.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Senate panel to vote on hospitals, PBMs, prisoner care

WSS

Researchers on aging grapple with how to calculate biological age

Medicare says breakthrough device reimbursement rule to come by summer

Telehealth options flood the market as retailers push virtual care

H5N1 bird flu: what we're starting to learn about infection in cows

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Sanofi strikes deal with Novavax, boosting the vaccine maker

entertainment

fashion

knowledge

Medical leaders decry Supreme Court decision on affirmative action

Senate panel to vote on hospitals, PBMs, prisoner care

ChatGPT in medicine: STAT answers readers' burning questions

Dairy farmers resist CDC push for PPE against bird flu virus

Tori Bowie and the unacceptable rates of Black maternal death

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Novavax promises a turnaround & Lilly roils the obesity market

Apple Watch's A

23andMe had bad news about my health. I wish a person had delivered it

Traditional Chinese medicine benefits explored in new JAMA study

knowledge

First recipient of genetically engineered pig kidney has died

Study: Adult vaccinations pay for themselves in societal benefits

Study: AI not yet building 'n

Chimpanzees, like humans and whales, get menopause: Study

Paying for Covid pills will soon shift to insurers

Study: AI not yet building 'n

knowledge

leisure time

hotspot

entertainment